Skip to main content

Novavax, Inc. (NVAX)

NASDAQ: NVAX · IEX Real-Time Price · USD
134.15
-1.20 (-0.89%)
After-hours:Oct 25, 2021 7:59 PM EDT
135.35
0.79 (0.59%)
At close: Oct 25, 4:00 PM
Market Cap9.83B
Revenue (ttm)1.18B
Net Income (ttm)-949.91M
Shares Out74.12M
EPS (ttm)-13.84
PE Ration/a
Forward PE2.90
Dividendn/a
Ex-Dividend Daten/a
Volume3,068,683
Open133.32
Previous Close134.56
Day's Range130.80 - 135.99
52-Week Range76.59 - 331.68
Beta1.59
AnalystsBuy
Price Target264.20 (+95.2%)
Est. Earnings DateNov 4, 2021

About NVAX

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate...

IndustryBiotechnology
IPO DateDec 5, 1995
CEOStanley Erck
Employees792
Stock ExchangeNASDAQ
Ticker SymbolNVAX
Full Company Profile

Financial Performance

In 2020, Novavax's revenue was $475.60 million, an increase of 2,448.48% compared to the previous year's $18.66 million. Losses were -$418.26 million, 215.2% more than in 2019.

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for Novavax stock is "Buy." The 12-month stock price forecast is 264.20, which is an increase of 95.20% from the latest price.

Price Target
$264.20
(95.20% upside)
Analyst Consensus: Buy

News

NOVAVAX INVESTIGATED: The Klein Law Firm Announces an Investigation on Behalf of Novavax, Inc. Investors

New York, New York--(Newsfile Corp. - October 25, 2021) - The Klein Law Firm has begun an investigation into Novavax, Inc. ("Novavax" or the "Company") (NASDAQ: NVAX) concerning possible violations of f...

7 hours ago - Newsfile Corp

Novavax Investor Alert

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $200,000 In Novavax To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor...

7 hours ago - Newsfile Corp

Novavax is Now a Riskier Play, but Still One to Keep Your Eye On

NVAX stock is even more of a gamble thanks to manufacturing issues, but the next move for the beaten-down shares could still be up. The post Novavax is Now a Riskier Play, but Still One to Keep Your Eye...

9 hours ago - InvestorPlace

The Law Offices of Frank R. Cruz Announces Investigation of Novavax, Inc. (NVAX) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)---- $NVAX #investors--The Law Offices of Frank R. Cruz Announces Investigation of Novavax, Inc. (NVAX) on Behalf of Investors

12 hours ago - Business Wire

INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Novavax, Inc. and Encourages I...

LOS ANGELES, Oct. 25, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Novavax, Inc. ("Novavax...

13 hours ago - PRNewsWire

NOVAVAX ALERT: Bragar Eagel & Squire, P.C. Is Investigating Novavax, Inc. on Behalf of Novavax Stockholders and Encou...

NEW YORK--(BUSINESS WIRE)-- #Novavax--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Novavax, Inc. (“Novavax” or the “Company...

14 hours ago - Business Wire

Are Atea Pharmaceuticals, Agenus, Novavax, and Ocular Therapeutix Bad News Buy?

Biotech stocks that fall hard on bad news can rebound in a flash.

Other symbols:AGENAVIROCUL
1 day ago - The Motley Fool

Novavax Update

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $200,000 In Novavax To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor...

1 day ago - Newsfile Corp

Novavax Is Set to Win on the Increasing Necessity of Booster Shots

NVAX stock has dropped a significant amount recently, but this could be a terrific buying opportunity for savvy long-term investors. The post Novavax Is Set to Win on the Increasing Necessity of Booster...

3 days ago - InvestorPlace

Why Novavax Fell by 3% Today

Good news for a rival's coronavirus vaccine compounds worries about the company's shot.

3 days ago - The Motley Fool

NVAX SHAREHOLDERS- Possible Securities Fraud Violations by Novavax, Inc.: The Law Offices of Vincent Wong Investigate

New York, New York--(Newsfile Corp. - October 22, 2021) - The Law Offices of Vincent Wong announce an investigation of Novavax, Inc. ("Novavax" or the "Company") (NASDAQ: NVAX) concerning possible viola...

3 days ago - Newsfile Corp

NOVAVAX INVESTIGATION: Block & Leviton Is Investigating Novavax Inc. For Potential Securities Law Violations; Investo...

Boston, Massachusetts--(Newsfile Corp. - October 22, 2021) - Block & Leviton is investigating Novavax Inc. (NASDAQ: NVAX) for potential securities law violations. Investors who have lost money in their ...

3 days ago - Newsfile Corp

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Novavax, Inc. and Encourages...

LOS ANGELES--(BUSINESS WIRE)---- $NVAX #NVAX--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Novavax, Inc. (“Nova...

3 days ago - Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Novavax, Inc. (NVAX) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)---- $NVAX #CLASSACTION--Law Offices of Howard G. Smith announces an investigation on behalf of Novavax, Inc. (“Novavax” or the “Company”) (NASDAQ: NVAX) investors concerni...

3 days ago - Business Wire

Novavax Faces 1 Major Risk Right Now. Should You Buy the Stock Anyway?

Novavax shares plummeted 15% in one trading session this week.

3 days ago - The Motley Fool

What's the Outlook for Novavax Stock?

Novavax's prospects depend on the company resolving its manufacturing issues.

3 days ago - The Motley Fool

3 Dirt-Cheap Stocks Wall Street Thinks Will Soar 43% to 80%

Analysts are bullish about these bargains.

Other symbols:JAZZVTRS
3 days ago - The Motley Fool

Why BioNTech and RedHill Are Soaring This Week, While Novavax Is Sinking

All three have COVID-19 connections.

Other symbols:BNTXRDHL
3 days ago - The Motley Fool

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Novavax, Inc. and Encourages In...

LOS ANGELES--(BUSINESS WIRE)---- $NVAX #NVAX--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Novavax, Inc.

4 days ago - Business Wire

Novavax (NVAX) Outpaces Stock Market Gains: What You Should Know

Novavax (NVAX) closed the most recent trading day at $138.79, moving +1.41% from the previous trading session.

4 days ago - Zacks Investment Research

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Novavax, Inc. (NVAX) on ...

LOS ANGELES--(BUSINESS WIRE)---- $NVAX #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf...

4 days ago - Business Wire

NVAX Alert: Berman Tabacco Announces Investigation of Novavax, Inc. for Potential Securities Law Violations

Boston, Massachusetts--(Newsfile Corp. - October 21, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Novavax, Inc. ("Novavax" ...

4 days ago - Newsfile Corp

Novavax Shareholder Alert

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $200,000 In Novavax To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor...

4 days ago - Newsfile Corp

Novavax (NVAX) Down on COVID Jab-Manufacturing Problem Reports

Novavax's (NVAX) shares fall on reports of the company's manufacturing problems related to its COVID-19 vaccine candidate.

4 days ago - Zacks Investment Research

NVAX ALERT: The Gross Law Firm Investigates Possible Securities Fraud Violations by Novavax, Inc.

New York, New York--(Newsfile Corp. - October 21, 2021) - ATTENTION NVAX INVESTORS:The Gross Law Firm is investigating Novavax, Inc. ("Novavax" or the "Company") (NASDAQ: NVAX) concerning possible viola...

4 days ago - Newsfile Corp